NRC Health (NRC) Earnings Analysis
NRC Health (NRC) has no confirmed upcoming earnings date. Trailing P/E 52.94.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NRC next report earnings?
No confirmed upcoming earnings date is currently scheduled for NRC. This page updates as the calendar is published.
NRC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-10-27 | 0.23 USD | n/a | n/a | n/a |
| 2025-07-28 | 0.28 USD | n/a | n/a | n/a |
| 2025-04-28 | 0.25 USD | n/a | n/a | n/a |
| 2024-10-25 | 0.24 USD | n/a | n/a | n/a |
NRC valuation and analyst view
| Trailing P/E | 52.94 |
|---|---|
| Trailing EPS | 0.41442 USD |
| Price / book | 34.88 |
| Dividend yield | 2.78% |
| Market cap | 0.48B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is NRC Health (NRC)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for NRC. This page updates as the calendar is published.
Did NRC beat earnings last quarter?
Consensus estimate data was not available for NRC's 2025-10-27 report.
What is NRC's current P/E ratio and EPS?
NRC trades at a trailing P/E of 52.94 on trailing EPS of 0.41442267993944676 USD.
What do analysts rate NRC?
NRC has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.